LogicBio Therapeutics, Inc. Operating Cash Flow
LogicBio Therapeutics, Inc. reported Operating Cash Flow of -$20.10 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-11-14
- LogicBio Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$7.18M.
- LogicBio Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$3.02M, a 166.40% decline year-over-year.
- LogicBio Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$9.90M.
- LogicBio Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$5.16M.
- LogicBio Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$19.00M.
- LogicBio Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$28.93M.
- LogicBio Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$38.75M.
- LogicBio Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2017 was -$5.78M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$7.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$10.20M derived: sum of 2 quarters · filed 2022-11-14 | -$20.10M 10-Q · filed 2022-11-14 | -$25.26M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | -$3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$12.92M 10-Q · filed 2022-08-15 | -$18.08M derived: sum of 3 quarters · filed 2022-08-15 | -$28.39M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | -$9.90M 10-Q · filed 2022-05-16 | -$15.06M derived: sum of 2 quarters · filed 2022-05-16 | -$25.37M derived: sum of 3 quarters · filed 2022-11-14 | -$20.82M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | -$5.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | -$15.47M derived: sum of 2 quarters · filed 2022-11-14 | -$10.92M derived: sum of 3 quarters · filed 2022-11-14 | -$19.00M 10-K · filed 2022-03-04 |
| 2021-09-30 | -$10.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$5.76M derived: sum of 2 quarters · filed 2022-11-14 | -$13.83M 10-Q · filed 2022-11-14 | -$21.32M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $4.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$3.53M 10-Q · filed 2022-08-15 | -$11.02M derived: sum of 3 quarters · filed 2022-08-15 | -$16.61M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$8.07M 10-Q · filed 2022-05-16 | -$15.56M derived: sum of 2 quarters · filed 2022-05-16 | -$21.15M derived: sum of 3 quarters · filed 2022-05-16 | -$29.46M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$7.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | -$13.08M derived: sum of 2 quarters · filed 2022-03-04 | -$21.39M derived: sum of 3 quarters · filed 2022-03-04 | -$28.93M 10-K · filed 2022-03-04 |
| 2020-09-30 | -$5.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$13.90M derived: sum of 2 quarters · filed 2021-11-15 | -$21.44M 10-Q · filed 2021-11-15 | -$33.14M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$8.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$15.85M 10-Q · filed 2021-08-09 | -$27.55M derived: sum of 3 quarters · filed 2021-08-09 | -$37.63M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$7.54M 10-Q · filed 2021-05-10 | -$19.24M derived: sum of 2 quarters · filed 2021-05-10 | -$29.33M derived: sum of 3 quarters · filed 2021-05-10 | -$38.06M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | -$11.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$21.79M derived: sum of 2 quarters · filed 2021-03-15 | -$30.52M derived: sum of 3 quarters · filed 2021-03-15 | -$38.75M 10-K · filed 2021-03-15 |
| 2019-09-30 | -$10.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$18.82M derived: sum of 2 quarters · filed 2020-11-09 | -$27.05M 10-Q · filed 2020-11-09 | -$31.69M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$8.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$16.96M 10-Q · filed 2020-08-10 | -$21.60M derived: sum of 3 quarters · filed 2020-08-10 | -$25.91M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | -$8.23M 10-Q · filed 2020-05-11 | -$12.87M derived: sum of 2 quarters · filed 2020-05-11 | -$17.18M derived: sum of 3 quarters · filed 2020-05-11 | -$20.34M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$4.64M derived: 10-Q 12 month − 10-Q 9 month · filed 2020-05-11 | -$8.95M derived: sum of 2 quarters · filed 2020-05-11 | -$12.11M derived: sum of 3 quarters · filed 2020-05-11 | -$15.27M 10-Q · filed 2020-05-11 |
| 2018-09-30 | -$4.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$7.47M derived: sum of 2 quarters · filed 2019-11-12 | -$10.63M 10-Q · filed 2019-11-12 | -$13.45M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$6.32M 10-Q · filed 2019-08-13 | -$9.14M derived: sum of 3 quarters · filed 2019-08-13 | |
| 2018-03-31 | -$3.15M 10-Q · filed 2019-05-14 | -$5.98M derived: sum of 2 quarters · filed 2019-05-14 | ||
| 2017-12-31 | -$2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$5.78M 10-K · filed 2019-04-01 | ||
| 2017-09-30 | -$2.96M 10-Q · filed 2018-12-03 |